menu
    • menu
    [{"orgOrder":0,"company":"Ferndale Laboratories, Inc.","sponsor":"Ferndale Laboratories, Inc.","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Miscellaneous","year":"2010","type":"Inapplicable","leadProduct":"Pimecrolimus","moa":"FK506-binding protein 1A","graph1":"Dermatology","graph2":"Phase IV","graph3":"Ferndale Laboratories, Inc.","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Cream","sponsorNew":"Ferndale Laboratories, Inc. \/ Ferndale Laboratories, Inc.","highestDevelopmentStatusID":"11","companyTruncated":"Ferndale Laboratories, Inc. \/ Ferndale Laboratories, Inc."},{"orgOrder":0,"company":"Ferndale Laboratories, Inc.","sponsor":"Ferndale Laboratories, Inc.","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"","productType":"Plant Extract\/Herbal","year":"2013","type":"Inapplicable","leadProduct":"Arnica Montana","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Phase IV","graph3":"Ferndale Laboratories, Inc.","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Ferndale Laboratories, Inc. \/ Ferndale Laboratories, Inc.","highestDevelopmentStatusID":"11","companyTruncated":"Ferndale Laboratories, Inc. \/ Ferndale Laboratories, Inc."}]

    Find Clinical Drug Pipeline Developments & Deals by Ferndale Laboratories, Inc.

    Menu

    Ferndale Laboratories, Inc.

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Ferndale Laboratories, Inc.

                            U.S.A arrow
                            Tides Europe
                            Not Confirmed

                            Ferndale Laboratories, Inc.

                            U.S.A arrow
                            Tides Europe
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Arnica Montana

                            Therapeutic Area : Undisclosed

                            Study Phase : Phase IV

                            Recipient : Center for Clinical and Cosmetic Research

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Study to Assess DerMend Moisturizing Bruise Formula in Improving the Appearance of Chronically Aged Forearms a...

                            Details : Arnica montana is a Other Large Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Plant Extract/Herbal

                            Upfront Cash : Inapplicable

                            July 30, 2013

                            Lead Product(s) : Arnica Montana

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Phase IV

                            Recipient : Center for Clinical and Cosmetic Research

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Ferndale Laboratories, Inc.

                            U.S.A arrow
                            Tides Europe
                            Not Confirmed

                            Ferndale Laboratories, Inc.

                            U.S.A arrow
                            Tides Europe
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Pimecrolimus

                            Therapeutic Area : Dermatology

                            Study Phase : Phase IV

                            Recipient : Emer, Jason, M.D.

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Pimecrolimus Cream 1% (Elidel®) and Medicated Device Cream (EletoneTM) in the Treatment and Maintenance of ...

                            Details : Pimecrolimus is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Dermatitis, Atopic.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            August 09, 2010

                            Lead Product(s) : Pimecrolimus

                            Therapeutic Area : Dermatology

                            Highest Development Status : Phase IV

                            Recipient : Emer, Jason, M.D.

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth